🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of acetaminophen, asserting the firms hid safety concerns that the medication posed to children's cognitive development.

The court filing follows thirty days after Former President Trump advocated an unsubstantiated connection between using Tylenol - alternatively called paracetamol - while pregnant and autism spectrum disorder in young ones.

Paxton is taking legal action against Johnson & Johnson, which previously sold the drug, the only pain reliever recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "betrayed America by making money from pain and promoting medication regardless of the dangers."

The manufacturer asserts there is insufficient reliable data connecting acetaminophen to autism.

"These manufacturers deceived for years, deliberately risking numerous people to increase profits," Paxton, from the Republican party, said.

The company stated officially that it was "very worried by the spread of false claims on the reliability of acetaminophen and the possible consequences that could have on the health of American women and children."

On its online platform, Kenvue also mentioned it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a verified association between consuming paracetamol and autism spectrum disorder."

Groups acting on behalf of medical professionals and health professionals concur.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the primary component in acetaminophen - is a restricted selection for expectant mothers to address discomfort and fever, which can pose significant medical dangers if ignored.

"In over twenty years of studies on the utilization of paracetamol in gestation, not a single reputable study has successfully concluded that the use of acetaminophen in any stage of gestation causes neurological conditions in children," the organization said.

The court filing mentions current declarations from the Trump administration in arguing the medication is allegedly unsafe.

Last month, the former president caused concern from public health officials when he advised pregnant women to "fight like hell" not to take Tylenol when sick.

The FDA then issued a notice that doctors should consider limiting the consumption of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in young ones has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had vowed in April to undertake "a massive testing and research effort" that would establish the source of autism in a short period.

But specialists advised that identifying a single cause of autism spectrum disorder - considered by experts to be the result of a complicated interplay of genetic and external influences - would prove challenging.

Autism is a type of lifelong neurodivergence and condition that impacts how individuals experience and relate to the world, and is recognized using doctors' observations.

In his lawsuit, Paxton - a Trump ally who is campaigning for federal office - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

This legal action aims to force the companies "destroy any promotional materials" that states Tylenol is secure for pregnant women.

The court case echoes the complaints of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in two years ago.

Judicial authorities threw out the legal action, saying investigations from the family's specialists was not conclusive.